Sironax
company
About
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $200M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Sep 1, 2017
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world.
Sironax was founded in 2017 and is based in Beijing, China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$200M
Sironax has raised a total of
$200M
in funding over 2 rounds. Their latest funding was raised on
Aug 2, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 2, 2022 | Series B | $200M | 3 |
Gaorong Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Sironax is funded by 3 investors.
Gaorong Capital
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaorong Capital
|
Yes | Series B |
ARCH Venture Partners
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
